1. CURRICULUM VITAE
Dr. K. Swati
B.H.M.S
E-mail:kolluru.swati@gmail.com
Mob No: +91 8884818000
CAREER OBJECTIVE:
An institute, which give opportunity to show me my talent and also mentor me at each step of my career.
EDUCATIONAL QUALIFICATIONS:
Bachelor of homoeopathic medicine and Surgery (B.H.M.S) under the Hahnemann Homoeopathic Medical College
in Bhopal from Barkatullah University (2004-2011) With Aggregate of 67%.
Board of Intermediate education (M.P.C) From M.L.B, Chhindwara, MP
(2001-2003) With Aggregate of 70%.
Board of Secondary education (S.S.C) From Saraswathi Shishu Mandir, Chhindwara, MP
(2000-2001) With Aggregate of 84%.
ACHIEVEMENTS:
Achieved Gold Medal and Certificate of Merit for First Position in BHMS 2nd Prof Examination.
Achieved Gold Medal and Certificate of Merit for First Position in BHMS 3rd Prof Examination.
Achieved Gold Medal and Certificate of Merit for Third Position in BHMS 4th Prof Examination.
MEDICAL PRACTISE EXPERIENCE:
Worked as a Consultant Physician in Tara Homoeopathic Clinic.
On qualifying, worked with Govt Hospital Chhindwara not on regular basis for 6 months.
Able to diagnose, examine and treat acute and chronic diseases in patients of all ages.
Experience in Gynecology.
STRENGTH:
Excellent communication skills.
Good knowledge of clinical practice and protocol.
Hard working.
Motivated.
Optimistic.
PROJECT:
Anxiety Neurosis:
Anxiety disorder is a blanket term covering several different forms of a type of mental illness of abnormal
and pathological fear and anxiety. Anxiety disorders are classified in two groups: continuous symptoms and
episodic symptoms.
The term anxiety covers four aspects of experiences an individual may have: mental apprehension, physical
tension, physical symptoms and dissociative anxiety. Anxiety disorder is divided into generalized anxiety
disorder, phobic disorder, and panic disorder; each has its own characteristics and symptoms and they require
different treatment.
The most important clinical point to emerge from studies of social anxiety disorder is the benefit of early
diagnosis and treatment. Social anxiety disorder remains under-recognized in primary practice, with patients
often presenting for treatment only after the onset of complications such as clinical depression or substance
abuse disorders.
Treatment:
2. Treatment options available include lifestyle changes; psychotherapy, especially cognitive behavioral
therapy; and pharmaceutical therapy. Education, reassurance and some form of cognitive-behavioral therapy
should almost always be used in treatment. Two forms of treatment available for social phobia: certain
medications and a specific form of short-term psychotherapy called cognitive-behavioral therapy (CBT), the
central component being gradual exposure therapy.
Pre-Eclampsia:
Pre-eclampsia or preeclampsia is a medical condition in which hypertension arises
in pregnancy (pregnancy-induced hypertension) in association with significant amounts of protein in the
urine.
Pre-eclampsia refers to a set of symptoms rather than any causative factor, and there are many different causes
for the condition. It appears likely that there are substances from the placenta that can cause endothelial
dysfunction in the maternal blood vessels of susceptible women.[1]
While blood pressure elevation is the most
visible sign of the disease, it involves generalized damage to the maternal endothelium, kidneys, and liver, with
the release of vasoconstrictive factors being secondary to the original damage.
Pre-eclampsia may develop from 20 weeks gestation. Its progress differs among patients; most cases are
diagnosed pre-term. Pre-eclampsia may also occur up to six weeks post-partum. Apart from Caesarean
section or induction of labor, there is no known cure. It is the most common of the dangerous pregnancy
complications; it may affect both the mother and the unborn child.
Treatment:
The only known treatments for eclampsia or advancing pre-eclampsia are abortion or delivery, either by labor
induction or Caesarean section. However, post-partum pre-eclampsia may occur up to six weeks following
delivery even if symptoms were not present during the pregnancy. Post-partum pre-eclampsia is dangerous to
the health of the mother since she may ignore or dismiss symptoms as simple post-delivery headaches and
edema. Hypertension can sometimes be controlled with anti-hypertensive medication, but any effect this might
have on the progress of the underlying disease is unknown.
In low-risk pregnancies the association between cigarette smoking and a reduced risk of pre-eclampsia has
been consistent and reproducible across epidemiologic studies. High-risk pregnancies (those with pregestational
diabetes, chronic hypertension, history of pre-eclampsia in a previous pregnancy, or multifetal gestation) showed
no significant protective effect. The reason for this discrepancy is not definitively known; research supports
speculation that the underlying pathology increases the risk of pre-eclampsia to such a degree that any
measurable reduction of risk due to smoking is swamped. A study into the effects of smoking on the incidence of
pre-eclampsia in African-American women found a significantly lower incidence of pre-eclampsia with higher
measured levels of nicotine. When adjusted for age, parity, and medical comorbidities the association was still
observable, but no longer significant. Medical authorities and anti-smoking advocates discourage smoking in
general during pregnancy.
DECLARATION:
I hereby declare that all the information given above are true and correct to the best My Knowledge and belief.
(Dr. K. SWATI)